CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 195 filers reported holding CLOVIS ONCOLOGY INC in Q3 2018. The put-call ratio across all filers is 0.31 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2020 | $3,375,000 | -64.6% | 500,000 | -66.7% | 0.09% | -76.7% |
Q1 2020 | $9,540,000 | -47.7% | 1,500,000 | -14.3% | 0.40% | -42.8% |
Q4 2019 | $18,244,000 | +828.4% | 1,750,000 | +250.0% | 0.70% | +792.4% |
Q3 2019 | $1,965,000 | -45.3% | 500,000 | +150.0% | 0.08% | -40.6% |
Q4 2018 | $3,592,000 | -21.0% | 200,000 | +100.0% | 0.13% | +37.1% |
Q2 2018 | $4,547,000 | -65.6% | 100,000 | -60.0% | 0.10% | -41.2% |
Q1 2018 | $13,200,000 | -22.4% | 250,000 | 0.0% | 0.16% | -35.8% |
Q4 2017 | $17,000,000 | +79.4% | 250,000 | +117.4% | 0.26% | +57.7% |
Q3 2017 | $9,476,000 | +304.8% | 115,000 | +360.0% | 0.16% | +297.6% |
Q2 2017 | $2,341,000 | +5.4% | 25,000 | -50.0% | 0.04% | -16.3% |
Q4 2016 | $2,221,000 | – | 50,000 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Versant Venture Management, LLC | 814,833 | $45,630,648,000 | 43.63% |
EcoR1 Capital, LLC | 384,348 | $21,523,000 | 10.89% |
Palo Alto Investors LP | 2,102,857 | $117,760,000 | 6.91% |
NEA Management Company, LLC | 2,279,781 | $127,668,000 | 6.19% |
Redmile Group, LLC | 721,632 | $40,411,000 | 4.40% |
Opaleye Management Inc. | 140,000 | $7,840,000 | 3.96% |
CLIFTON PARK CAPITAL MANAGEMENT, LLC | 790,555 | $44,271,000 | 2.63% |
SUFFOLK CAPITAL MANAGEMENT LLC | 339,327 | $19,002,000 | 2.31% |
PFM Health Sciences, LP | 1,725,126 | $96,607,000 | 2.26% |
HARBOURVEST PARTNERS LLC | 51,037 | $2,858,000 | 1.50% |